Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Myriad Genetics Inc Company Overview 7
Myriad Genetics Inc Company Snapshot 7
Myriad Genetics Inc Pipeline Products and Ongoing Clinical Trials Overview 7
Myriad Genetics Inc – Pipeline Analysis Overview 10
Business Description 10
Myriad Genetics Inc – Key Facts 10
Myriad Genetics Inc – Major Products and Services 11
Myriad Genetics Inc Pipeline Products by Development Stage 13
Myriad Genetics Inc Ongoing Clinical Trials by Trial Status 16
Myriad Genetics Inc Pipeline Products Overview 18
BRACAnalysis CDx – Talazoparib 18
BRACAnalysis CDx – Talazoparib Product Overview 18
ChemoPredict Test 19
ChemoPredict Test Product Overview 19
Diagnostic Assay – Lung Cancer 20
Diagnostic Assay – Lung Cancer Product Overview 20
Diagnostic Assay – HER2+/TNBC-Breast Cancer 21
Diagnostic Assay – HER2+/TNBC-Breast Cancer Product Overview 21
Diagnostic Assay – Juvenile Idiopathic Rheumatoid Arthritis 22
Diagnostic Assay – Juvenile Idiopathic Rheumatoid Arthritis Product Overview 22
Diagnostic Assay – Melanoma 23
Diagnostic Assay – Melanoma Product Overview 23
Diagnostic Assay – Prostate Cancer 24
Diagnostic Assay – Prostate Cancer Product Overview 24
Diagnostic Test – Alzheimer’s Disease 25
Diagnostic Test – Alzheimer’s Disease Product Overview 25
Diagnostic Test – Colon Cancer 26
Diagnostic Test – Colon Cancer Product Overview 26
Diagnostic Test – Kidney Damage 27
Diagnostic Test – Kidney Damage Product Overview 27
GeneSight Test – MDD 28
GeneSight Test – MDD Product Overview 28
GeneSight Test – MDD Clinical Trial 29
Genetic Risk Score Test 30
Genetic Risk Score Test Product Overview 30
Genetic Risk Score Test Clinical Trial 31
HRD Companion Diagnostic Test – Breast Cancer 32
HRD Companion Diagnostic Test – Breast Cancer Product Overview 32
Kidney Transplant Rejection Test 33
Kidney Transplant Rejection Test Product Overview 33
Multi-Biomarker Test – Ankylosing Spondylitis 34
Multi-Biomarker Test – Ankylosing Spondylitis Product Overview 34
Multi-Biomarker Test – Autoimmune Diseases 35
Multi-Biomarker Test – Autoimmune Diseases Product Overview 35
Multi-Biomarker Test – Inflammatory Diseases 36
Multi-Biomarker Test – Inflammatory Diseases Product Overview 36
Multi-Biomarker Test – Psoriatic Arthritis 37
Multi-Biomarker Test – Psoriatic Arthritis Product Overview 37
Multi-Biomarker Test – Systemic Lupus Erythematosus 38
Multi-Biomarker Test – Systemic Lupus Erythematosus Product Overview 38
myChoice Diabetes 39
myChoice Diabetes Product Overview 39
myChoice HRD (PARP) – Niraparib 40
myChoice HRD (PARP) – Niraparib Product Overview 40
myChoice HRD (PARP) – Niraparib Clinical Trial 41
myChoice HRD (PARP) – Talazoparib 43
myChoice HRD (PARP) – Talazoparib Product Overview 43
myChoice HRD (PARP) – Talazoparib Clinical Trial 44
myChoice HRD (Platinum) 45
myChoice HRD (Platinum) Product Overview 45
myChoice HRD (Platinum) Clinical Trial 46
myPath BiPolar 47
myPath BiPolar Product Overview 47
myPath Endometriosis 48
myPath Endometriosis Product Overview 48
myPath Pancreatic Cancer 49
myPath Pancreatic Cancer Product Overview 49
myPath Prostate Cancer 50
myPath Prostate Cancer Product Overview 50
myPath Psoriatic Arthritis 51
myPath Psoriatic Arthritis Product Overview 51
myPlan Renal Cancer 52
myPlan Renal Cancer Product Overview 52
myRisk Schizophrenia 53
myRisk Schizophrenia Product Overview 53
Prognostic Test – Bladder Cancer 54
Prognostic Test – Bladder Cancer Product Overview 54
SanoPredict 55
SanoPredict Product Overview 55
Tumor BRACAnalysis CDx – Veliparib 56
Tumor BRACAnalysis CDx – Veliparib Product Overview 56
VeriPsych Test – Bipolar Disorder 57
VeriPsych Test – Bipolar Disorder Product Overview 57
Myriad Genetics Inc – Key Competitors 58
Myriad Genetics Inc – Key Employees 59
Myriad Genetics Inc – Key Employee Biographies 60
Myriad Genetics Inc – Locations And Subsidiaries 61
Head Office 61
Other Locations & Subsidiaries 61
Recent Developments 63
Myriad Genetics Inc, Recent Developments 63
Jul 18, 2018: Myriad announces coverage decision by Kroger Prescription Plans for Vectra DA 63
Jun 28, 2018: BRACAnalysis CDx Identifies Patients Who Respond to Lynparza in SOLO-1 Study 63
Jun 21, 2018: Top-Five National Payer Issues Positive Coverage Decision for Myriad’s Prolaris Test for Prostate Cancer 63
Jun 18, 2018: Myriad’s BRACAnalysis CDx Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer 64
Jun 06, 2018: Crescendo Bioscience Announces Four Studies with Vectra DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting 64
Jun 01, 2018: Myriad Genetics Presents Second Pivotal Validation Study for riskScore Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting 65
May 31, 2018: GeneSight Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting 66
May 23, 2018: Myriad Announces Seven New Payer Coverage Decisions for Prolaris 67
May 15, 2018: Myriad Genetics to Present Eight Studies at the 2018 American Society of Clinical Oncology Annual Meeting 67
May 15, 2018: New Publication on Counsyl’s Foresight Carrier Screen Validates the Highly Accurate Detection of Couples At-Risk for Children With Serious Disease 69
Appendix 71
Methodology 71
About GlobalData 74
Contact Us 74
Disclaimer 74
Myriad Genetics Inc Pipeline Products and Ongoing Clinical Trials Overview 7
Myriad Genetics Inc Pipeline Products by Equipment Type 8
Myriad Genetics Inc Pipeline Products by Indication 9
Myriad Genetics Inc Ongoing Clinical Trials by Trial Status 9
Myriad Genetics Inc, Key Facts 10
Myriad Genetics Inc, Major Products and Services 11
Myriad Genetics Inc Number of Pipeline Products by Development Stage 13
Myriad Genetics Inc Pipeline Products Summary by Development Stage 14
Myriad Genetics Inc Ongoing Clinical Trials by Trial Status 16
Myriad Genetics Inc Ongoing Clinical Trials Summary 17
BRACAnalysis CDx - Talazoparib - Product Status 18
BRACAnalysis CDx - Talazoparib - Product Description 18
ChemoPredict Test - Product Status 19
ChemoPredict Test - Product Description 19
Diagnostic Assay - Lung Cancer - Product Status 20
Diagnostic Assay - Lung Cancer - Product Description 20
Diagnostic Assay - HER2+/TNBC-Breast Cancer - Product Status 21
Diagnostic Assay - HER2+/TNBC-Breast Cancer - Product Description 21
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis - Product Status 22
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis - Product Description 22
Diagnostic Assay - Melanoma - Product Status 23
Diagnostic Assay - Melanoma - Product Description 23
Diagnostic Assay - Prostate Cancer - Product Status 24
Diagnostic Assay - Prostate Cancer - Product Description 24
Diagnostic Test - Alzheimer's Disease - Product Status 25
Diagnostic Test - Alzheimer's Disease - Product Description 25
Diagnostic Test - Colon Cancer - Product Status 26
Diagnostic Test - Colon Cancer - Product Description 26
Diagnostic Test - Kidney Damage - Product Status 27
Diagnostic Test - Kidney Damage - Product Description 27
GeneSight Test - MDD - Product Status 28
GeneSight Test - MDD - Product Description 28
GeneSight Test - MDD - PRIME Care (Precision Medicine In Mental Health Care) 29
Genetic Risk Score Test - Product Status 30
Genetic Risk Score Test - Product Description 30
Genetic Risk Score Test - Clinical Trial to Examine Use of Predictive Genetic Tests for Cancer Risks Assessment 31
HRD Companion Diagnostic Test - Breast Cancer - Product Status 32
HRD Companion Diagnostic Test - Breast Cancer - Product Description 32
Kidney Transplant Rejection Test - Product Status 33
Kidney Transplant Rejection Test - Product Description 33
Multi-Biomarker Test - Ankylosing Spondylitis - Product Status 34
Multi-Biomarker Test - Ankylosing Spondylitis - Product Description 34
Multi-Biomarker Test - Autoimmune Diseases - Product Status 35
Multi-Biomarker Test - Autoimmune Diseases - Product Description 35
Multi-Biomarker Test - Inflammatory Diseases - Product Status 36
Multi-Biomarker Test - Inflammatory Diseases - Product Description 36
Multi-Biomarker Test - Psoriatic Arthritis - Product Status 37
Multi-Biomarker Test - Psoriatic Arthritis - Product Description 37
Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Status 38
Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Description 38
myChoice Diabetes - Product Status 39
myChoice Diabetes - Product Description 39
myChoice HRD (PARP) - Niraparib - Product Status 40
myChoice HRD (PARP) - Niraparib - Product Description 40
myChoice HRD (PARP) - Niraparib - A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy 41
myChoice HRD (PARP) - Niraparib - A Phase II, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients with Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens 41
myChoice HRD (PARP) - Niraparib - Phase I of Bevacizumab-Niraparib Combination. AVANOVA2 -A 3-arm, Phase II Randomized Study of Niraparib &/or Niraparib-bevacizumab Combination Against Bevacizumab Alone in HRD Platinum-sensitive Epithelial Ovarian Cancer: AVANOVA1 42
myChoice HRD (PARP) - Talazoparib - Product Status 43
myChoice HRD (PARP) - Talazoparib - Product Description 43
myChoice HRD (PARP) - Talazoparib - A Phase II Clinical Trial of the PARP Inhibitor Talazoparib in BRCA1 and BRCA2 Wild-type Patients with (i) Advanced Triple-negative Breast Cancer and Homologous Recombination Deficiency, and (ii) Advanced HER2-negative Breast Cancer or Other Solid Tumors with Either a Mutation in Homologous Recombination Pathway Genes 44
myChoice HRD (Platinum) - Product Status 45
myChoice HRD (Platinum) - Product Description 45
myChoice HRD (Platinum) - A Randomized Phase II Study of Preoperative Cisplatin Versus Paclitaxel in Patients with Triple Negative Breast Cancer: Evaluating the Homologous Recombination Deficiency (HRD) Biomarker 46
myPath BiPolar - Product Status 47
myPath BiPolar - Product Description 47
myPath Endometriosis - Product Status 48
myPath Endometriosis - Product Description 48
myPath Pancreatic Cancer - Product Status 49
myPath Pancreatic Cancer - Product Description 49
myPath Prostate Cancer - Product Status 50
myPath Prostate Cancer - Product Description 50
myPath Psoriatic Arthritis - Product Status 51
myPath Psoriatic Arthritis - Product Description 51
myPlan Renal Cancer - Product Status 52
myPlan Renal Cancer - Product Description 52
myRisk Schizophrenia - Product Status 53
myRisk Schizophrenia - Product Description 53
Prognostic Test - Bladder Cancer - Product Status 54
Prognostic Test - Bladder Cancer - Product Description 54
SanoPredict - Product Status 55
SanoPredict - Product Description 55
Tumor BRACAnalysis CDx - Veliparib - Product Status 56
Tumor BRACAnalysis CDx - Veliparib - Product Description 56
VeriPsych Test - Bipolar Disorder - Product Status 57
VeriPsych Test - Bipolar Disorder - Product Description 57
Myriad Genetics Inc, Key Employees 59
Myriad Genetics Inc, Key Employee Biographies 60
Myriad Genetics Inc, Subsidiaries 61
Glossary 73
List of Figures
Myriad Genetics Inc Pipeline Products by Equipment Type 8
Myriad Genetics Inc Pipeline Products by Development Stage 13
Myriad Genetics Inc Ongoing Clinical Trials by Trial Status 16